The global hemorrhoid treatment market was valued at USD 1.03 billion in 2023 and is expected to expand from USD 1.08 billion in 2024 to USD 1.74 billion by 2032, reflecting a compound annual growth rate (CAGR) of 6.1% throughout the forecast period.
Hemorrhoids are a common condition characterized by swollen and inflamed veins in the rectum and anus, leading to discomfort and bleeding. This condition affects millions of people globally and can result from various factors, including straining during bowel movements, prolonged sitting, obesity, pregnancy, and chronic constipation.
Request a Free Sample PDF Brochure : https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/hemorrhoid-treatment-market-110985
In September 2024, Haleon Group of Companies agreed to acquire Tianjin TSKF Pharmaceutical Co. Ltd., China. This acquisition aimed to deliver greater control and increased strategic and operational flexibility across the business. This move is expected to enhance Haleon's market position and expand its product portfolio in the hemorrhoid treatment industry.